A distinct form of spiral-shaped bacilli has been identified as a potential etiologic agent in the pathogenesis of gastritis and ulcers (2, 7) . This organism is currently called Campylobacterpylori, but may belong to a distinct new genus (16) . C. pylori can be identified in gastric tissue specimens by culture and histologic staining techniques. Both of these are timeconsuming, and a rapid test that can accurately identify C. pylori-infected patients would expedite therapeutic decisions. Several investigators have tried to use the strong urease reaction of C. pylori.by placing fresh antral tissue in Christensen's urea broth and observing it for a change in color, which would indicate the presence of urease (1, 3, 4, 14) . However, there are several reports of false-positive results with this technique (4, 5) . In some of these studies, the indicator broth was incubated at room temperature (4, 14) and read after 24 h (4, 5, 14 (9) . Histopathologic specimens were stained with Giemsa stain (10) and observed for presence of characteristic 2.5-,um-long, spiral-shaped organisms as originally described by Marshall (12) . An (12) were seen after Giemsa staining or if C. pylori was cultured from the biopsy. All positive cultures had oxidase-positive, catalase-positive, and urease-positive organisms with characteristic morphology after Gram staining (9 value of 85%. Sensitivity was 83%, and the negative predictive value was 71%.
The goal of our study was to find a rapid test with a high specificity so that patients with C. pylori infections could be accurately identified without having to wait up to a week for results of culture or pathology tests. We used a small volume of reagent, 0.5 ml, to achieve a high inoculum/reagent ratio. A temperature of 37°C was used to accommodate postbiopsy urease production in the event that preformed amounts were inadequate. When performed in this manner and read after 1 h, our test had the desired specificity and a positive predictive value of 100%. On the other hand, we found the 74% specificity with the alternative 24-h cutoff time to be too low for the purposes of the test.
This increased rate of false-positive readings could be caused by an instability of the reagent over time or by chemical reactions from autolysis of the tissue. Another possibility is presence of contaminants with a lower urease activity than C. pylori, which need prolonged incubation to cause the test to read positive. Contamination of biopsies with oral flora is not uncommon and is one of the reasons selective media are used for primary isolation of C. pylori. When sampled, one of our 24-h, false-positive vials did indeed contain a urease-producing contaminant. Only the last three of our late-positive vials were tested in this way, however, and we are therefore unable to estimate how frequently such contamination may occur.
The 100% specificity of our urease test was ideal for rapid identification of patients with C. pylori infection. However, the lower sensitivity of 67% means that some infected patients would still be missed on an initial screening. These patients would nevertheless be properly identified when results of culture and pathology tests became available. When dealing with a chronic disease such as C. pyloriassociated gastritis, we feel that the additional wait of 4 to 7 days for proper diagnosis in these cases would not lead to any significant increase in morbidity.
Improved sensitivity might be accomplished by increasing the number of organisms free to react with the urease broth. Hazell et al. (11) have used a smaller volume of reagent (50 ,ul) placed in a well of a microdilution tray. With this method, they achieved a 91% sensitivity after 18 h. They did not list specific sensitivity data for readings after 1 h but noted that 75% of their positive biopsies reacted within the first hour, indicating a sensitivity comparable to ours. McNulty and Wise (15) have recommended gently mashing the biopsy with a sterile cotton swab in an attempt to disperse more bacteria into the reagent broth. This method needs further evaluation and may improve the sensitivity.
The advantages of a rapid diagnostic test with 100% specificity are obvious, and it was very satisfactory to find that the urease test performed so well at 1 h. This means that patients infected with C. pylori can be identified and given adequate information and instructions before they leave the endoscopy suite. Such instructions may include therapy aimed at eradicating the organism. Bismuth preparations, such as bismuth subsalicylate (Pepto-Bismol), have been shown to be active against C. pylori (8, 13, 17) . Optimal therapy may, however, be the combination of a bismuth salt and an antibiotic (6, 17) . With the help of the rapid urease test, such therapeutic modalities can be quickly and accurately instituted.
